Advance in ventricular assist devices and current controversies
Xuejun Xiao
Abstract
Xuejun Xiao
Abstract
Advanced heart failure(AHF) is a global epidemic with high morbidity and mortality. Heart transplantation has been the main method for the treatment of AHF. However, for the extreme shortage of organ donations, heart transplantation is no obvious increase. Left ventricular assist devices(LVADs) have become a viable therapeutic approach as a bridge to heart transplantation, as well as destination therapy or part of the bridge to recovery. This review focuses on the therapeutic effect with VAD, current controversies and prospects.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Advanced heart failure(AHF) is a global epidemic with high morbidity and mortality. Heart transplantation has been the main method for the treatment of AHF. However, for the extreme shortage of organ donations, heart transplantation is no obvious increase. Left ventricular assist devices(LVADs) have become a viable therapeutic approach as a bridge to heart transplantation, as well as destination therapy or part of the bridge to recovery. This review focuses on the therapeutic effect with VAD, current controversies and prospects.
Key concepts: Economic shortage, Medicine, Bridge to transplantation, Heart transplantation, Transplantation, Intensive care medicine, Destination therapy, Bridge (graph theory)